GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Total Assets

Kobayashi Pharmaceutical Co (TSE:4967) Total Assets : 円261,253 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Total Assets?

Kobayashi Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was 円261,253 Mil.

During the past 12 months, Kobayashi Pharmaceutical Co's average Total Assets Growth Rate was 25.70% per year. During the past 3 years, the average Total Assets Growth Rate was 9.20% per year. During the past 5 years, the average Total Assets Growth Rate was 4.10% per year. During the past 10 years, the average Total Assets Growth Rate was 4.20% per year.

During the past 13 years, Kobayashi Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 9.50%. The lowest was -14.50%. And the median was 2.90%.

Total Assets is connected with ROA %. Kobayashi Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 1.48%. Total Assets is also linked to Revenue through Asset Turnover. Kobayashi Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.14.


Kobayashi Pharmaceutical Co Total Assets Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Total Assets Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 233,732.00 238,366.00 252,554.00 255,827.00 267,473.00

Kobayashi Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 252,903.00 266,573.00 270,937.00 267,473.00 261,253.00

Kobayashi Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kobayashi Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=204816+62657
=267,473

Kobayashi Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=204967+56286
=261,253

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kobayashi Pharmaceutical Co  (TSE:4967) Total Assets Explanation

Total Assets is connected with ROA %.

Kobayashi Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=3904/( (267473+261253)/ 2 )
=3904/264363
=1.48 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kobayashi Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=36485/( (267473+261253)/ 2 )
=36485/264363
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kobayashi Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Traded in Other Exchanges
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines